Cognition Therapeutics
A drug discovery and development company that helps restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. Learn more
Launch date
Employees
Market cap
CAD33.2m
Enterprise valuation
(CAD5m) (Public information from Sep 2024)
Share price
$0.609 CGTX
Town of Harrison New York (HQ), Pittsburgh Pennsylvania (founding location)
Authorizing premium user...